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Abstract
We describe a patient with biventricular assist devices who had systemic inflammation because of cholecystitis that
required open cholecystectomy, and we discuss the anesthetics and monitors that should be used in unstable
patients with ventricular assist devices (VADs) who are undergoing major surgery.
The patient was a 40-year-old man in the dilated phase of hypertrophic obstructive cardiomyopathy, who was
implanted with an internal left VAD and external right VAD. We anesthetized the patient with a combination of a
low dose of sevoflurane and ketamine to minimize vasodilation. We chose ketamine because we expected it to
have a postoperative analgesic effect. An INVOS™ (Medtronic) monitor was beneficial, especially since the pulse
oximeter did not work because of a pulse deficit. The FloTrach™ (Edwards Lifesciences) failed to measure the
stroke volume and its variability. The left VAD, the Jarvik2000, did not show its flow rate. However, we were able
to estimate that the flow was stabilized, because the flow rate of the right VAD was stable, and there was no
significant change in both ventricles and septa, as shown on transesophageal echocardiography.
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Background
Ventricular assist devices (VADs) are increasingly indicated
in patients with acute or chronic heart failure refractory to
medication. They are used as a temporary mechanical as-
sist, permanent therapy, or bridging therapy for heart
transplantation. It is common for physicians to manage
anesthetic drugs in patients with VADs who undergo non-
cardiac surgeries or procedures that require sedation such
as gastrointestinal endoscopy. Successful management with
non-invasive monitors has been reported in patients who
have relatively stable hemodynamics [1–3]; however, man-
aging unstable patients who are undergoing major surgery
is challenging. We describe a patient with systemic inflam-
mation and biventricular assist devices (BiVADs) who
underwent laparotomic cholecystectomy.
Case presentation
Written informed consent was obtained from the patient
to publish this case report. A 40-year-old male patient
with BiVAD support required cholecystectomy because
of cholecystitis that could not be controlled with internal
medication. He was diagnosed as having hypertrophic
obstructive cardiomyopathy (HOCM) at the age of 25.
His heart function became increasingly worse after
HOCM progressed to the dilated phase. Severe heart
failure occurred when he was 39 years old, and his circu-
lation and oxygenation were insufficient even with medi-
cation, intra-aortic balloon pumping, and percutaneous
cardiopulmonary support. Surgical aortic valve replace-
ment, tricuspid valve plasty, and external left VAD
(LVAD) installation were performed; however, he did not
recover and right heart failure advanced. An external
right VAD was required, and the LVAD was converted
to an implanted one (Jarvik2000, Jarvik Heart, Inc., New
York, NY) while the patient waited for heart transplant-
ation. During these treatments for heart failure, he
developed non-occlusive mesenteric ischemia and ileus,
which required open abdominal surgery four times
under general anesthesia. Soon after BiVAD surgery, he
developed cholecystitis. Percutaneous transhepatic gall-
bladder drainage and antibiotics were continued for
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1 month, but these treatments were ineffective.
Cholecystectomy with laparotomy was planned because
laparoscopic surgery was considered difficult, as the
pipelines and drivelines of the VADs would prevent the
use of an appropriate approach, and we expected strong
adhesion caused by previous laparotomies.
He had been managed in an intensive care unit (ICU)
for more than 200 days before the surgery. An arterial
catheter and central venous catheter were placed pre-
operatively. He was not sedated and spontaneously venti-
lated, although tracheostomy had been performed, and
supplemental oxygen was required because he had not re-
covered from a BiVAD procedure-related lung injury. No
inotrope or vasoconstrictor was used preoperatively.
Warfarin was discontinued 5 days before the surgery, and
intravenous unfractionated heparin was administered until
6 h preoperatively. The international normalized ratio of
prothrombin time (PT-INR) was 1.2 just before the patient
entered the operating theater. General anesthesia was
induced and maintained with a low dose of sevoflurane
inhalation (0.8 to 1.0% end-tidal concentration) combined
with a sub-anesthetic, intravenous dose of ketamine
(30 mg bolus administration followed by a 0.5 mg/kg/h
continuous infusion). Muscular relaxation was obtained
using rocronium, and the patient was mechanically
ventilated throughout the operation. Pressure control
ventilation was chosen with the peak inspiratory pressure
20 cmH2O, respiratory rate from 10 to 12 times per mi-
nute and positive end-expiratory pressure 4 cmH2O. In
addition to the basic monitors, we placed an INVOS™
(Medtronic, Minneapolis, MN) on the patient’s forehead
to detect cerebral tissue oxygenation and on the foot to
determine peripheral tissue oxygenation. We performed
transesophageal echocardiography (TEE) using a pediatric
probe to avoid esophageal injury, as a 14-French nasogas-
tric tube was placed preoperatively, and the surgeons re-
quested us to maintain it intraoperatively. We converted
the arterial pressure measurement kit to the FloTrach™
(Edwards Lifesciences, Irvine, CA) to test its feasibility, al-
though it could not estimate the stroke volume because of
the low amplitude of waveform. The Jarvik2000 did not
show the flow rate, so we estimated that the flow was stabi-
lized because TEE did not show any significant change in
the size and shape of both ventricles and septa, and the ex-
ternal right VAD flow rate was maintained at 3.8–3.9 L/min
throughout the procedure.
Intraoperative analgesia was obtained with ketamine,
and a 0.1 μg/kg/min infusion of remifentanil. 300 μg of
fentanyl was administered to achieve the predicted target
blood concentration 1 μg/ml at the time of postoperative
ICU admission.
The surgeons had difficulty separating the adhesion
and achieving hemostasis. When the blood loss exceeded
300 mL, we observed a moderate decrease in the mean
blood pressure (from 60 to 50 mmHg) and central ven-
ous pressure (from 7 to 5 cmH2O), and a temporary de-
crease in the pulse oximetry value (Fig. 1). However,
there was no decrease in the flow of the VADs, and TEE
showed no change in the right and left ventricular sizes.
We decided to transfuse two units of packed red blood
cells when the blood loss reached 400 mL, because the
patient had preoperative anemia. After transfusion, the
blood pressure, central venous pressure, and pulse oxim-
etry values restored. The surgery was successfully fin-
ished. The durations of surgery and anesthesia were 191
and 270 min, respectively. The total volume of infusion,
bleeding, and urine were 810, 420, 45 mL, respectively.
We did not use any inotropes or vasoconstrictors. We
performed a transversus abdominis plane block using a
posterior approach postoperatively. We awoke the pa-
tient in the operating theater, and his spontaneous venti-
lation recovered. Postoperative adverse events associated
with anesthetic management were not observed. Postop-
erative analgesic effect of intraoperative low dose keta-
mine and transversus abdominis plane block was unclear
because the patient was slightly sedated using dexmede-
tomidine during the first postoperative 24 h in the ICU,
and we could not assess the pain scale. Cholecystitis was
successfully treated, although he required furthermore
ICU stay to manage hemodynamics and wound infection
around the LVAD driveline exit cite. He underwent heart
transplantation after a 120-day waiting duration from
the cholecystectomy.
Discussion
We successfully performed anesthetic management in a
patient with BiVAD support who underwent laparotomic
cholecystectomy. The type of anesthetic agent, the deci-
sion of transfusion, and invasive monitors we used are
important parts of our management.
Various anesthetic agents have been used during non-
cardiac surgery in patients with LVAD, although no
specific one has been recommended yet [4, 5]. We used
ketamine combined with a low dose of sevoflurane,
because ketamine causes sympathetic stimulation [6]
and can be a good choice for hemodynamically unstable
patients [7]. We also chose ketamine because of its post-
operative analgesic effect, which has been previously re-
ported [8, 9]. Other possible agents we could have used
to minimize a negative hemodynamic effect include mid-
azolam, dexmedetomidine, and etomidate. We did not
use midazolam, because it had been administered to the
patient over a long duration in the ICU, and we were in-
formed that the patient might have developed a toler-
ance to it. We did not use dexmedetomidine, because
using this agent for anesthetic maintenance is consid-
ered off-label use in our country. Regarding etomidate, it
is not available in our country.
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We transfused red blood cells even though blood loss
was insignificant. In previous reports on patients with
LVAD who underwent cholecystectomy, blood transfu-
sion was necessary in approximately half of the cases
[10, 11]. We decided to transfuse blood despite the pre-
served hemodynamic parameters because the patient
had preoperative anemia, and there was the possibility of
early postoperative bleeding. The blood oozing did not
completely stop even though a large amount of oxidized
cellulose was used. We should have considered this issue
with point-of-care transfusion; however, point-of-care
coagulation and platelet function testing devices were
not available at that time.
In patients with continuous flow VADs, obtaining a
non-invasive blood pressure measurement by using the
automated cuff and pulse oximeter is sometimes unreli-
able because of the narrow pulse pressure. Near infrared
spectroscopy may be feasible in such patients [12]. When
we observed a temporal pulse-wave deficit and the pulse
oximeter did not work well, the INVOS™ provided us with
important information about the central and peripheral
oxygenation. We also used it to detect the possibility of
cerebral infarction. Warfarin was discontinued to reduce
the risk of perioperative bleeding, and the PT-INR was
maintained around 1.2. It is important to detect cerebral
thrombosis as soon as possible, because it is associated
with a high mortality rate in patients with VADs [13].
Concerning invasive monitors, arterial and central
venous catheters were already placed in our patient and
we only added TEE. Stone et al. reported that the oppor-
tunity to use an invasive arterial pressure monitoring
catheter and central venous access catheter was decreas-
ing, and TEE was only used in less than 15% of 291
non-cardiac procedures performed over 10 years at their
institution [1]. However, the use of TEE was important
because the Jarvik2000 does not show its flow rate.
Fig. 1 Trends in the perioperative mean blood pressure, central venous pressure, oxygen saturation of the pulse oximeter, and regional saturation
of oxygen. MBP mean blood pressure, CVP central venous pressure, rSO2 regional saturation of oxygen, LH left head, RH right head, LF left foot,
RF right foot, SpO2 oxygen saturation of the pulse oximeter, A start of anesthesia, S start of surgery, B bleeding, T transfusion, E end of surgery
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The intraoperative flow of the right ventricular assist
device was stable, and TEE showed that there was no
significant change in the size and shape of both ventri-
cles, and no shifting of the septa. Thus, we were able to
estimate that the flow of the LVAD was also stable.
Moreover, we could detect the mechanical obstruction
of pipelines of the VAD by TEE. However, successful im-
aging is not promised when a gastric tube is placed sim-
ultaneously. Moreover, the risk of esophageal injury may
be increased even though we use a pediatric probe. We
also should carefully consider the risk of bleeding
because patients with VADs may have a coagulation
abnormality. Additionally, the risk and benefit of TEE
should be considered in each case before it is used.
Conclusions
We successfully managed the anesthetics of a patient
with BiVADs who underwent open cholecystectomy.
Anesthesia and analgesia were achieved with sevoflur-
ane, ketamine, remifentanil, fentanyl, and a TAP block
under stable hemodynamic parameters without any dys-
function of the VADs. INVOS™ was beneficial, whereas
FloTrach™ was not. TEE was also useful, although its in-
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